Agfa-Gevaert has executed the definitive agreements for acquisition of long-time technology partner Mitra. The deal, which is expected to close in early January, is subject only to completion of the premerger clearance process. The two companies
Agfa-Gevaert has executed the definitive agreements for acquisition of long-time technology partner Mitra. The deal, which is expected to close in early January, is subject only to completion of the premerger clearance process. The two companies announced the signing of a letter of intent regarding the sale in late September. Mitra, a provider of imaging and information management systems for the healthcare enterprise, has played an integral role in the development and success of Agfa's IMPAX PACS solutions for the past 10 years. Mitra will be managed as a separate business unitthe company structure, management team, and all employees will be retained.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.